Online citations, reference lists, and bibliographies.

Pathology Of In-stent Restenosis.

Renu Virmani, Andrew Farb
Published 1999 · Biology, Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
The process of in-stent restenosis parallels wound healing responses. Stent deployment results in early thrombus deposition and acute inflammation, granulation tissue development, and ultimately smooth muscle cell proliferation and extracellular matrix synthesis. The severity of arterial injury during stent placement correlates with increased inflammation and late neointimal growth. These pathological findings provide useful targets for therapies aimed at reducing the incidence of in-stent restenosis.



This paper is referenced by
10.1016/j.carrev.2012.12.009
Unintentional extraction of an endothelialized bare metal stent.
Jaskiran K Cheema (2013)
10.1016/S0008-6363(03)00520-0
Differential localisation of the renin-angiotensin system in de-novo lesions and in-stent restenotic lesions in in-vivo human coronary arteries.
Lodewijk J. Wagenaar (2003)
Long stents Suboptimal stent deployment Bifurcation lesions Ostial location of the lesion Increased number of stents per lesion Multiple vessels stented Diabetes
Michael Shapiro (2004)
10.1002/9781119242642.CH14
Applications of Biopolymer-based, Surface-modified Devices in Transplant Medicine and Tissue Engineering
Ashim Malhotra (2016)
10.1016/j.cardiores.2005.06.026
Interleukin-1 receptor antagonist alters the response to vessel wall injury in a porcine coronary artery model.
Allison C. Morton (2005)
10.1136/heart.89.3.317
Evaluation of intracoronary stenting by intravascular optical coherence tomography
Brett E. Bouma (2003)
10.1097/01.fjc.0000246940.91191.1f
Stent-Based Delivery of Antisense Oligodeoxynucleotides Targeted to the PDGF A-Chain Decreases In-Stent Restenosis of the Coronary Artery
Yuxin Li (2006)
Zur Bedeutung von PPARβ/δ in der Atherosklerose und Restenose unter besonderer Berücksichtigung peripherer restenotischer Läsionen
M. Wilhelm (2013)
10.1007/s00270-004-0341-9
The Road to Bioabsorbable Stents: Reaching Clinical Reality?
P. Erne (2004)
10.1097/LBR.0b013e318191f00b
Short-term Placement of Multiple Self-expandable Metallic Stents for the Treatment of Bilateral Bronchial Dehiscences Complicating Lung Transplantation.
Meltem Tor (2009)
10.1007/978-1-4471-4429-8_26
Endovascular Femoropopliteal Interventions: Evolving Devices
Cassidy A Duran (2013)
Evolution of Coronary Stents: From Bare-Metal Stents to Fully Biodegradable, Drug-Eluting Stents
Jason FoerstMarc (2013)
10.1111/j.1540-8183.2009.00423.x
Passive and active polymer coatings for intracoronary stents: novel devices to promote arterial healing.
Lakshmana K Pendyala (2009)
10.1007/978-981-10-2787-1_17
Late Stent Evaluation (Neoatherosclerosis)
Jung-Hee Lee (2018)
Ultrasound-guided percutaneous delivery of tissue- engineered endothelial cells to the adventitia of stented arteries controls the response to vascular injury in a Citation
Yin-Shan Ng (2013)
10.3349/ymj.2013.54.5.1075
Stent Evaluation with Optical Coherence Tomography
Seung-Yul Lee (2013)
10.1001/jama.295.11.1264
Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial.
David R Holmes (2006)
10.1097/00001573-200209000-00012
Can we prevent in-stent restenosis?
Luis Díaz-Santana Garza (2002)
10.1074/jbc.M116.741967
Smooth Muscle Cell Proangiogenic Phenotype Induced by Cyclopentenyl Cytosine Promotes Endothelial Cell Proliferation and Migration*
Rui Tang (2016)
10.1016/j.bbrc.2005.03.175
Targeting of αv integrins interferes with FAK activation and smooth muscle cell migration and invasion
Jeeva Varadarajulu (2005)
10.1007/978-1-4471-4429-8_6
Endovascular Treatment of Carotid Disease: Inflammatory Aspects
Sthefano Atique Gabriel (2013)
Die Rolle von Thrombozyten beim postnatalen Verschluss des Ductus arteriosus der Maus
Vollständiger Abdruck (2012)
10.1016/j.atherosclerosis.2009.05.036
Active matrix metalloproteinases 3 and 9 are independently associated with coronary artery in-stent restenosis.
Gregory T Jones (2009)
10.1161/01.ATV.0000017994.77066.75
Distinction in Genetic Determinants for Injury-Induced Neointimal Hyperplasia and Diet-Induced Atherosclerosis in Inbred Mice
David G. Kuhel (2002)
10.2143/AC.59.1.2005159
Drug-eluting stents: a new treatment in the prevention of restenosis Part I: experimental studies
Koen J Salu (2004)
10.17077/etd.lbif0oq0
Photopolymerized materials and patterning for improved performance of neural prosthetics
Bradley W. Tuft (2014)
10.1002/9781444319446.CH37
Novel Drug Eluting Stent Systems
Adriano Caixeta (2011)
AN EXPERIMENTAL APPROACH TO RESTENOSIS AND TRANSPLANT ARTERIOSCLEROSIS
Hanna Savolainen-Peltonen (2004)
10.1038/s41598-019-43821-3
Soluble adenylyl cyclase links Ca2+ entry to Ca2+/cAMP-response element binding protein (CREB) activation in vascular smooth muscle
Tony Parker (2019)
10.1002/jbm.b.32772
Surface chemical and physical modification in stent technology for the treatment of coronary artery disease.
Feroze Nazneen (2012)
10.1007/s00270-008-9392-7
Reduction of Late In-Stent Stenosis in a Porcine Coronary Artery Model by Cobalt Chromium Stents with a Nanocoat of Polyphosphazene (Polyzene-F)
Ulrike Stampfl (2008)
Expert consensus (SBC/SBHCI) on the use of drug-eluting stents: recommendations of the Brazilian society of interventional cardiology/ Brazilian society of cardiology for the Brazilian public single healthcare system.
Valter Correia de Lima (2006)
See more
Semantic Scholar Logo Some data provided by SemanticScholar